After stratifying the PCa patients by their E-cadherin staining pattern, we evaluated the distribution of the clinicopathologic data and biomarkers (Phospho-Rb S249, N-cadherin, and β-catenin) expression (Tables 8 and 9) in each category. Here, CDH2 is linked to posterior cortical atrophy.